Table 1:

Baseline characteristics of patients, lesions and excisions, by treatment group

CharacteristicGroup; no. (%) of patients*
Alcoholic chlorhexidine (intervention) n = 454Aqueous chlorhexidine (control) n = 462
Patient
Age, yr, mean ± SD (range)65.1 ± 14.2 (21–91)64.8 ± 13.9 (21–101)
Sex, male266 (58.6)251 (54.3)
Smoking status
 Current smoker33 (7.3)39 (8.4)
 Ex-smoker128 (28.2)135 (29.2)
 Never smoked293 (64.5)288 (62.3)
Comorbid conditions
 Any99 (21.8)105 (22.7)
 Diabetes mellitus44 (9.7)53 (11.5)
 Ischemic heart disease43 (9.5)53 (11.5)
 COPD16 (3.5)10 (2.2)
Medications
 Taking a medication131 (28.9)128 (27.7)
 Oral anticoagulant agents65 (14.3)75 (16.2)
 Oral antiplatelet agents42 (9.3)35 (7.6)
 Oral or inhaled steroids or other immunosuppressant39 (8.6)30 (6.5)
Lesion
Body site
 Head and neck154 (33.9)174 (37.7)
 Trunk84 (18.5)81 (17.5)
 Upper limb114 (25.1)127 (27.5)
 Lower limb: below knee80 (17.6)64 (13.9)
 Lower limb: above knee22 (4.8)16 (3.5)
Histologic findings
 Malignant melanoma11 (2.4)9 (1.9)
 Basal cell carcinoma or squamous cell carcinoma257 (56.6)254 (55.0)
 Cancerous precursor§69 (15.2)77 (16.7)
 Other lesion117 (25.8)122 (26.4)
Excision
Type of excision
 Simple443 (97.6)453 (98.1)
 Two-layer or flap11 (2.4)9 (1.9)
Suture size
 Thick (2/0 or 3/0)277 (61.0)269 (58.2)
 Thin (4/0, 5/0 or 6/0)116 (25.6)130 (28.1)
 Multiple61 (13.4)63 (13.6)
Length of excision, mm, median (range)25.0 (3–100)25.0 (3–100)
Time to removal of sutures, d, mean ± SD (range)9.69 ± 2.95 (3–19)9.73 ± 2.97 (4–21)
  • Note: COPD = chronic obstructive pulmonary disease, SD = standard deviation.

  • * Except where indicated otherwise.

  • Comorbid conditions were diabetes mellitus, peripheral vascular disease, ischemic heart disease, cancer and inflammatory skin disease.

  • Medications were steroids (oral or inhaled), anticoagulants, antiplatelet agents, opioids (oral or cutaneous) and other immunosuppressive medications.

  • § Cancerous precursors were actinic keratoses and dysplastic nevi.